PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chronic Hepatitis B Virus (HBV)

Gilead's Vemlidy (Tenofovir Alafenamide) Receives NMPA (CFDA) Approval for Chronic Hepatitis B Virus (HBV) Infection

Gilead's Vemlidy (Tenofovir Alafenamide) Receives NMPA (CFDA) Approval for Chronic Hepatitis B Virus (HBV) Infection"

November 19, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us